“…[5] At the same time, selective ligands that carry a spin label [6] or that change their optical properties when bound to the AP site [7] may be used for the sensitive detection of these lesions. Along these lines, several ligands have been shown to bind to AP sites, for example, naphthyridine derivatives, [8] nucleic-base intercalator conjugates, [9,10] aminoalkyl-substituted DNA intercalators, [11,12] DNA intercalators such as proflavine, [13] annelated quinolizinium derivatives, [14] or berberine, [15] cyclic bisacridines, [16] or metalloinsertors with sterically expansive ligands.…”